Dealbreaker on MSN5 天
The Big Three Pharmacy Benefit Managers Are Countersuing the FTC. Does Their Argument Have ...
The FTC filed a lawsuit in September, accusing the three major PBMs of anticompetitive rebating practices related to insulin.
The Pharma Letter8 天
Novo Nordisk slashes insulin prices to focus on GLP-1s
Novo Nordisk to slash US prices of Tresiba and Fiasp insulins by over 70% from 2026, enhancing diabetes access. The company ...
verywellhealth27 天
How Pancreatitis Is Linked to Diabetes
Insulin and glucagon are two hormones made in and released by the pancreas that regulate blood glucose levels. Insulin works to lower blood glucose levels by acting as a key to open cells, allowing ...